罕见VPS33B基因变异合并GP1BA变异致血浆VWF水平严重降低:一例病例报告及文献复习
一例28岁女性孕期常规检查发现凝血因子Ⅷ活性(FⅧ∶C)<1%、血管性血友病因子抗原(VWF∶Ag)<1%,二代测序未发现VWF基因外显子区域致病变异,因临床表现与Ⅲ型血管性血友病(VWD)不符,采用三代测序对患者及家系行全基因组测序,发现父系多位成员携带VPS33B基因杂合变异c.869G>C,携带者VWF水平降低(39%~56%),先证者还检出GP1BA基因杂合变异c.1474dupA,ACMG及Clinvar数据库判断其与血小板型假性VWD相关。
要点
- VPS33B基因杂合变异c.869G>C家系成员VWF水平降低(39%~56%),为国际首次报道。
- 先证者同时检出GP1BA基因杂合变异c.1474dupA,数据库判断与血小板型假性VWD相关。
- VPS33B与GP1BA双重杂合变异引起血浆VWF水平严重降低此前未见报道。
核心结论
- VPS33B基因杂合变异导致家系成员VWF水平降低为国际首次报道,VPS33B与GP1BA双重杂合变异引起血浆VWF水平严重降低此前未见报道。
研究设计与样本
- 病例报告及文献复习:一例28岁女性孕期常规体检发现FⅧ∶C<1%、VWF∶Ag<1%,二代测序未发现VWF基因外显子区域致病变异。
- 因临床表现与Ⅲ型VWD不符,采用三代测序技术对该患者及其家系成员进行全基因组测序。
主要发现
- 患者父系家族中多位成员携带VPS33B基因杂合变异c.869G>C,携带该变异的家系成员均有不同程度VWF水平降低(39%~56%)。
- 先证者检出GP1BA基因杂合变异c.1474dupA,ACMG及Clinvar数据库判断该变异与血小板型假性VWD相关。
- 患者FⅧ∶C<1%、VWF∶Ag<1%,二代测序未发现VWF基因外显子区域致病变异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A 28-year-old woman was found to have coagulation factor Ⅷ activity (FⅧ∶C) <1% and von Willebrand factor antigen (VWF∶Ag) <1% during routine prenatal examinations. No pathogenic variation was found in the exon region of the VWF gene using next-generation sequencing. The clinical presentation of this patient does not match the clinical characteristics of type Ⅲ hemophilia [von Willebrand disease (VWD) ]; therefore, third-generation sequencing technology was used to perform whole-genome sequencing on the patient and her family members. Multiple members of the patient's paternal family carried a heterozygous variant of VPS33B, c.869G>C. The family members carrying this variant all had varying degrees of reduced VWF levels (39% -56% ). Moreover, the proband was detected with the heterozygous variant c.1474dupA in GP1BA. The ACMG and Clinvar databases determined that this variation was associated with platelet-type pseudo VWD. The decrease in VWF levels caused by heterozygous variations in VPS33B in families is the first international report, and no previous studies have reported cases of severe decrease in plasma VWF levels caused by double heterozygous variations in VPS33B and GP1BA. 一例28岁女性,孕期常规体检发现凝血因子Ⅷ活性(FⅧ∶C)<1%、血管性血友病因子抗原(VWF∶Ag)<1%。二代测序未发现其VWF基因外显子区域存在致病变异。由于该患者临床表现与Ⅲ型血管性血友病(VWD)临床特征不符,因此采用三代测序技术对该患者及其家系成员进行全基因组测序,发现该患者父系家族中有多位成员中携带VPS33B基因杂合变异c.869G>C,携带该变异的家系成员均有不同程度的VWF水平降低(39%~56%)。同时,先证者还检出GP1BA基因杂合变异c.1474dupA,ACMG及Clinvar数据库判断该变异与"血小板型假性VWD"相关。VPS33B基因杂合变异导致的VWF水平降低家系为国际首次报道,VPS33B基因与GP1BA基因双重杂合变异引起血浆VWF水平严重降低病例之前也未见报道。.
引用
- Ma SQ, Bai X, Cao LJ, et al. [Rare VPS33B gene mutation combined with GP1BA mutation causes severe decrease in plasma VWF levels: a case report and literature review]. Zhonghua Xue Ye Xue Za Zhi. 2024. PMID: 39134495. doi:10.3760/cma.j.cn121090-20231216-00317
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。